{"entities":{"Q6694542":{"pageid":14413520,"ns":120,"title":"Item:Q6694542","lastrevid":54639917,"modified":"2026-01-29T18:50:58Z","type":"item","id":"Q6694542","labels":{"en":{"language":"en","value":"Analysis of human humoral responses in a typhoid vaccine efficacy trial used for SIMON analysis"}},"descriptions":{"en":{"language":"en","value":"Dataset published at Zenodo repository."}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"dae155fd0809a7906855cd4fa50dd7d71bed552b","datavalue":{"value":{"entity-type":"item","numeric-id":56885,"id":"Q56885"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6694542$8932A850-A232-4BEF-BFC0-5E83EBAA0636","rank":"normal"}],"P1459":[{"mainsnak":{"snaktype":"value","property":"P1459","hash":"e8454fd0cad628446a8fe9128b03278bf2737fb8","datavalue":{"value":"The VAST dataset contains data from 72 individuals enrolled in the clinical study to evaluate humoral responses in a typhoid vaccine efficacy trial in a controlled human Salmonella Typhi infection model (see original publication: https://doi.org/10.3389/fimmu.2019.02582). Only day 0 (day of the challenge) log-transformed data were used in the SIMON analysis, as described in the publication (https://doi.org/10.1101/2020.08.16.252767). Individuals were vaccinated with either a purified Vi polysaccharide (Vi-PS) vaccine (35 individuals) or the Vi tetanus toxoid conjugate (Vi-TT) vaccine (37 individuals) one month prior to oral challenge with live Salmonella Typhi. Out of 72 individuals, 26 developed an acute typhoid infection following the challenge.","type":"string"},"datatype":"string"},"type":"statement","id":"Q6694542$44448C73-7DAC-4E5A-A5D2-C5093E433F0B","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"01c50b4ee19eeb3511cdd8197dfb2cf754f69622","datavalue":{"value":{"time":"+2020-10-23T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q6694542$3EBD735C-D2E9-44A4-9149-14DC4C21AB98","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"2368b525cced127017dbb4fa649c36b5e1f23425","datavalue":{"value":{"entity-type":"item","numeric-id":146452,"id":"Q146452"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6694542$CBA03F8B-980D-4E79-B3C6-1F502FFBDA31","rank":"normal"}],"P227":[{"mainsnak":{"snaktype":"value","property":"P227","hash":"797cd1d3cd0e329ca77d8bb4a8c05fedfcd3b73a","datavalue":{"value":"4121322","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6694542$A237ADBD-2684-48FC-9C30-3CA7EC13E541","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"7af3615fd2e9f654e3a7cd75404d2fa3cf4b15c5","datavalue":{"value":"10.5281/zenodo.4121322","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6694542$853E9691-7708-4CDE-A04B-239B89516186","rank":"normal"}],"P163":[{"mainsnak":{"snaktype":"value","property":"P163","hash":"45fcd4163b5f33e6e8c784f5522d7246c0a1a61e","datavalue":{"value":{"entity-type":"item","numeric-id":57056,"id":"Q57056"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6694542$23C85B37-F34E-44E4-B35E-B4B86DFA2888","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"d1e8073b72a070520efd3d14d4b3d2d3d03859e2","datavalue":{"value":{"entity-type":"item","numeric-id":5984635,"id":"Q5984635"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6694542$AB087231-D0FD-4C08-B2F7-E78103F1E40E","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Analysis of human humoral responses in a typhoid vaccine efficacy trial used for SIMON analysis","badges":[]}}}}}